Jay Erlebacher is a Cardiology physician affiliated with Seton Hall University. OpenAlex indexes 15 publications with 875 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
177 N Dean St
Suite 100
Englewood, NJ 076312533
Telephone
201-816-2508Registry record last updated 23 Aug 2007.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202547 payments
- Alnylam Pharmaceuticals Inc.Program year20255 payments
- PFIZER INC.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.2%Statin18%Atorvastatin Calcium57%Rosuvastatin Calcium40%Simvastatin3%Part D≥204 patientsBeta blocker13%Metoprolol Succinate34%Carvedilol26%Bisoprolol Fumarate20%Atenolol16%Metoprolol Tartrate4%Part D≥78 patients+ 15 more classes in this area
Blood & clotting
12.2%Factor Xa inhibitor10.4%Eliquis86%Xarelto14%Part D≥135 patientsP2Y12 inhibitor1.5%Clopidogrel100%Part D≥29 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.4%SGLT2 inhibitor2.9%Jardiance53%Farxiga47%Part D≥25 patientsProton pump inhibitor0.9%Pantoprazole Sodium69%Omeprazole32%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AORTIC VALVE AREA IS SUPERIOR TO AORTIC VALVE AREA INDEX OR JET VELOCITY AS A PREDICTOR OF SYMPTOMATIC HEART FAILURE IN PATIENTS WITH AORTIC STENOSIS
Journal of the American College of Cardiology
2011 - Intraventricular conduction delay and functional mitral regurgitation
The American Journal of Cardiology
2001 - Beta-blocker treatment of idiopathic and ischemic dilated cardiomyopathy in patients with ejection fractions ≤20%
The American Journal of Cardiology
1993
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”